Let's talk medical research

Living with rare diseases can be exceptionally challenging, and patients often must deal with years of misdiagnosis on their journey. A common refrain in the clinical trial recruitment industry is that patients are looking for trials and researchers are looking for patients — and nowhere is that truer than in the rare diseases community. Because rare diseases typically have limited treatment ...

One year ago, JDRF launched Antidote Match on the Clinical Trials Connection page. To mark the occasion, we sat down with our two main collaborators, Sydney Yovic, AVP of Research Operations and Mission, and Monica Harrington, Manager of Research Communications, to reflect on what we have learned over the last 12 months and to talk about the next steps for the partnership.

More than 5 million people live with Alzheimer’s today. By 2050, that number could rise to as high as 16 million. Currently, there is not an effective treatment for Alzheimer’s symptoms or anything that slows or stops the disease. Researchers are also investigating what steps we can take to prevent the disease in the first place.

Lupus Research Alliance, a member of the Antidote partnership network, is dedicated to finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE) by supporting medical research.

Today, we are pleased to announce a new partnership with the Lupus Research Alliance to help lupus patients and their loved ones find and understand their clinical trial options in a new way. Right now, there are more than 120 clinical studies for lupus, and they need more than 35,000 people to take part. It’s only by increasing the number of patients getting involved in research that we can ...

At Antidote, we’re all about people. We come to work each day to help people connect with medical research for a variety of conditions — and one of the key ways we do this is by working with our robust network of partners who believe in our shared mission to connect people with medical research. Our partners spend their days empowering patients, educating caregivers, advocating for research, and ...

MarlaJan Wexler of the Luck Fupus blog has an unbelievable health story. She’s a Philadelphia native who’s had more than her fair share of health issues – from a congenital heart defect to lupus to cancer – and yet, she remains a remarkably positive and upbeat advocate for patients. Today is World Lupus Day, and to recognize the difficulties of this invisible illness, and encourage all to raise ...

We've all heard them - the dreaded clinical trial myths.

We're thrilled to announce that today, we've launched our new MS search with our partner, the MS Association of America. Now, MS patients and their care partners can visit the MSAA website to be matched to a clinical trial in seconds. Why is this important? To answer this question, we asked Jeri Burtchell, Director of Patient Initiatives at HealthiVibe, LLC, MS advocate, and clinical trials ...

It takes at least 10 years and $2.6 billion on average for a new treatment to become available for the general population, which means that it is a big deal when critical medical advancements are made.1 It also means it’s a big deal when we take steps towards those medical advancements, which is why we’re so excited about our new partnership with Lung Cancer Alliance (if you haven’t yet, make ...